Nerpharma is a fully integrated drug development and manufacturing organization, operating as a strategic CDMO partner and true one-stop shop for high-potency products.
Located in Lombardy's Life Science Cluster (Milan), at the center of the European pharmaceutical hub, the site benefits from excellent transportation links and strong access to EU and global markets.
The industrial complex covers 200,000 m² and is specifically designed for highly complex and high-containment operations. The facilities are specialized in high-potency production, including oral solid dosage forms, high-potent injectables, and biologics, supporting advanced oncology and innovative therapies.
Nerpharma offers end-to-end CDMO services, covering both drug substance and drug product activities — from innovative pre-clinical development and clinical batches to full-scale commercial manufacturing.
The facilities operate under international regulatory standards and are approved by the AIFA/EMA, US FDA, PMDA and other health authorities.
